Universe Pharmaceuticals INC (NASDAQ:UPC) currently has a daily average trading volume of 12.36M but it saw 2495018 shares traded in last market. With a market cap of 0.77M USD, the company’s current market price of $0.09 came falling about -9.18 while comparing to the previous closing price of $0.10. In past 52 weeks, the stock remained buoying in the range of price level as high as $64.80 and as low as $0.09. In the recent trading on the day, stock has struck highest price mark of $0.0811 while lowest mark touched by it was $0.089.
Taking a look at 20-day trading activity of Universe Pharmaceuticals INC (UPC) gives us an average price of $0.1275, while its current price level is -99.86% below from 52-week high level whereas it is -1.11% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2786 while that of 200 days or SMA-200 reads an average of $18.0273. A closer look into the stock’s movement over the week reveals that its volatility is standing at 11.86% during that period while stretching the period over a month that increases to 16.19%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 27.56 which implies that the stock is in oversold territory.
Over the week, UPC’s stock price is moving -26.32% down while it is -40.43% when we observe its performance for the past one month. Year-to-date it is -85.41% down and over the past year, the stock is showing a downside performance of -99.62%.
The company is expected to be releasing its next quarterly report in April, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Universe Pharmaceuticals INC’s total number of outstanding shares is 8.66M with 0.91% of that held by the insiders while 3.70% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -64.36% and return on equity (ROE) at -50.22%. Stock’s beta reads 1.59. Stock has a price to book (P/B) ratio of 0.01 while price to sale or P/S ratio amounts to 0.03. Its return on asset (ROA) is -30.97% on average.
